|
Neil Flanzraich has served as Director since March 2002. Mr. Flanzraich has served as the Vice Chairman and President of IVAX Corporation a pharmaceutical manufacturer since May 1998. Mr. Flanzraich served as Chairman of Life Sciences Legal Practices Group of Heller Ehrman White & McAuliff a law firm from 1995 to 1998. From 1981 to 1994 Mr. Flanzraich served in various capacities at Syntex Corporation and as a member of the Corporate Executive Committee. From 1994 to 1995 after Syntex Corporation was acquired by Roche Holding Ltd. Mr. Flanzraich served as Senior Vice President and General Counsel of Syntex (USA) Inc. a Roche subsidiary. Mr. Flanzraich was Chairman of the Board of Directors of North American Vaccine Inc. from 1989 to 2000. Mr. Flanzraich also currently serves on the boards of IVAX IVAX Diagnostics Inc. and Rae Systems Inc. | 